Navina Raises $55M Series C to Expand AI-Powered Clinical Intelligence Platform
We’re thrilled to announce that our portfolio company, Navina, has raised a $55M in Series C funding round, led by Goldman Sachs Asset Management, with participation from Vertex Ventures Israel, ALIVE Israel HealthTech Fund, and Grove Ventures. This round brings Navina’s total funding to $100 million— thus meaning a major leap forward in its mission to transform healthcare through AI-driven clinical intelligence.
AI That Empowers Clinicians and Transforms Patient Outcomes
Over 10,000 clinicians across 1,300 clinics already trust Navina’s AI copilot for primary care, the core of its platform. In other words, the solution delivers real-time, proactive insights that help physicians understand their patients better, while reducing cognitive load, and make faster, more informed decisions.
While healthcare continues to shift toward value-based care, providers need tools that go beyond reactive workflows. For this reason, Navina is delivering exactly that—clinical intelligence that surfaces risks, recommends actions, and turns data into better care.
Furthermore, this funding will allow Navina to:
- Scale its platform and reach more providers
- Enhance product capabilities and AI performance
- Support a healthcare system increasingly focused on proactive, patient-centered care
Backing the Future of Smarter, Value-Based Healthcare
At Grove Ventures, we’ve believed in Navina’s vision from day one: to use technology to solve the most complex challenges in healthcare. By all means, we’re proud to continue supporting Ronen Lavi, Shay Perera, and the entire Navina team as they scale their impact and help shape the future of healthcare delivery.
Congratulations on this huge milestone—onward!
📌 Read more on Calcalist Tech: 🔗 Navina Raises $55M to Expand AI Clinical Intelligence